Telomerase regulation

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 730, Issue 1-2, 2012, Pages 20-27

  Cifuentes Rojas, Catherine ^a   Shippen, Dorothy E ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Repeat addition processivity; Ribonucleoprotein; Telomere; TERRA; TERT; TR

Indexed keywords

CELL PROTEIN; HELICASE; KU ANTIGEN; MKRN1 UBIQUITIN LIGASE E3; MYC PROTEIN; PIF1 PROTEIN; RIBONUCLEOPROTEIN; RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE RIBONUCLEOPROTEIN; TELOMERIC REPEAT CONTAINING RNA; TPP1 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UNTRANSLATED RNA; WT1 PROTEIN;

CHROMOSOME; CHROMOSOME TERMINUS; COILED BODY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE; GENE DOSAGE; GENE EXPRESSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PSEUDOURIDYLATION; REVIEW; TERT GENE; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; CHROMOSOMES; GENE DOSAGE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MODELS, MOLECULAR; RNA PROCESSING, POST-TRANSCRIPTIONAL; TELOMERASE; TELOMERE-BINDING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84855507810     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.10.003     Document Type: Review

References (128)

1. Greider C.W. Telomeres: telomerase and senescence. BioEssays 1990, 12:363-369.
2. Greenberg R.A. Telomeres, crisis and cancer. Curr. Mol. Med. 2005, 5:213-218.
3. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., Shay J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 1996, 18:173-179.
4. J. Prescott, I.M. Wentzensen, S.A. Savage, I. De Vivo, Epidemiologic evidence for a role of telomere dysfunction in cancer etiology, Mutat. Res., in press, Jul 2 [Epub ahead of print].
5. N.D. Nelson, A.A. Bertuch, Dyskeratosis congenita as a disorder of telomere maintenance, Mutat. Res., in press, Jul 2. [Epub ahead of print].
6. M. Armanios, Beyond dyskeratosis congenita: pulmonary phenotypes as a manifestation of telomerase insufficiency, Mutat. Res., in press.
7. Shippen D.E. Plant telomeres. Telomeres 2006, 525-550. Cold Spring Harbor Press. 2nd edition. T. deLange, V. Lundblad, E. Blackburn (Eds.).
8. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 26:867-874.
9. Cong Y.S., Wright W.E., Shay J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 2002, 66:407-425.
10. Cairney C.J., Keith W.N. Telomerase redifined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. Biochemie 2008, 90:13-23.
11. Kyo S., Takakura M., Fujiwara T., Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci. 2008, 99:1528-1538.
12. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell. Dev. Biol. 2000, 16:653-699.
13. Grandori C., Eisenman R.N. Myc target genes. Trends Biochem. Sci. 1997, 22:177-181.
14. Oh S., Song Y., Yim J., Kim T.K. The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J. Biol. Chem. 1999, 274:37473-37478.
15. Horikawa I., Barrett J.C. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003, 24:1167-1176.
16. Fujimoto K., Kyo S., Takakura M., Kanaya T., Kitagawa Y., Itoh H., Takahashi M., Inoue M. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. Nucleic Acids Res. 2000, 28:2557-2562.
17. Alonso M.M., Fueyo J., Yung W.K., Gomez-Manzano C. E2F1 and telomerase: alliance in the dark side. Cell Cycle 2006, 5:930-935.
18. Lacerte A., Korah J., Roy M., Yang X.J., Lemay S., Lebrun J.J. Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal 2008, 20:50-59.
19. Ballal R.D., Saha T., Fan S., Haddad B.R., Rosen E.M. BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage. J. Biol. Chem. 2009, 284:36083-36098.
20. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002, 108:171-182.
21. Shats I., Milyavsky M., Tang X., Stambolsky P., Erez N., Brosh R., Kogan I., Braunstein I., Tzukerman M., Ginsberg D., Rotter V. p53-dependent down-regulation of telomerase is mediated by p21waf1. J. Biol. Chem. 2004, 279:50976-50985.
22. Xu D., Wang Q., Gruber A., Bjorkholm M., Chen Z., Zaid A., Selivanova G., Peterson C., Wiman K.G., Pisa P. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 2000, 19:5123-5133.
23. Zhu J., Zhao Y., Wang S. Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell 2010, 1:22-32.
24. Wang S., Zhu J. Evidence for a relief of repression mechanism for activation of the human telomerase reverse transcriptase promoter. J. Biol. Chem. 2003, 278:18842-18850.
25. Xu D., Popov N., Hou M., Wang Q., Bjorkholm M., Gruber A., Menkel A.R., Henriksson M. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:3826-3831.
26. Wang S., Hu C., Zhu J. Transcriptional silencing of a novel hTERT reporter locus during in vitro differentiation of mouse embryonic stem cells. Mol. Biol. Cell. 2007, 18:669-677.
27. Atkinson S.P., Hoare S.F., Glasspool R.M., Keith W.N. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res. 2005, 65:7585-7590.
28. Wick M., Zubov D., Hagen G. Genomic organization and promoter chracterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 1999, 232:97-106.
29. Devereux T.R., Horikawa I., Anna C.H., Annab L.A., Afshari C.A., Barrett J.C. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res. 1999, 59:6087-6090.
30. Guilleret I., Benhattar J. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp. Cell. Res. 2003, 289:326-334.
31. Ohlsson R., Renkawitz R., Lobanenkov V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet. 2001, 17:520-527.
32. Renaud S., Loukinov D., Bosman F.T., Lobanenkov V., Benhattar J. CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res. 2005, 33:6850-6860.
33. Ulaner G.A., Hu J.F., Vu T.H., Oruganti H., Giudice L.C., Hoffman A.R. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium, International journal of cancer. J. Int. Cancer 2000, 85:330-335.
34. Rohde V., Sattler H.P., Bund T., Bonkhoff H., Fixemer T., Bachmann C., Lensch R., Unteregger G., Stoeckle M., Wullich B. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue. Clin. Cancer Res. 2000, 6:4803-4809.
35. Oguchi K., Tamura K., Takahashi H. Characterization of Oryza sativa telomerase reverse transcriptase and possible role of its phosphorylation in the control of telomerase activity. Gene 2004, 342:57-66.
36. Counter C.M., Hahn W.C., Wei W., Caddle S.D., Beijersbergen R.L., Lansdorp P.M., Sedivy J.M., Weinberg R.A. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14723-14728.
37. J. Podlevsky, J. Chen, Telomerase structure and biogenesis, Mutat. Res., in press.
38. Aisner D.L., Wright W.E., Shay J.W. Telomerase regulation: not just flipping the switch. Curr. Opin. Genet. Dev. 2002, 12:80-85.
39. Kang S.S., Kwon T., Kwon D.Y., Do S.I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 1999, 274:13085-13090.
40. Yang S.W., Jin E., Chung I.K., Kim W.T. Cell cycle-dependent regulation of telomerase activity by auxin, abscisic acid and protein phosphorylation in tobacco BY-2 suspension culture cells. Plant J. 2002, 29:617-626.
41. Kharbanda S., Kumar V., Dhar S., Pandey P., Chen C., Majumder P., Yuan Z.M., Whang Y., Strauss W., Pandita T.K., Weaver D., Kufe D. Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase. Curr. Biol. 2000, 10:568-575.
42. Minamino T., Kourembanas S. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ. Res. 2001, 89:237-243.
43. Kim J.H., Park S.M., Kang M.R., Oh S.Y., Lee T.H., Muller M.T., Chung I.K. Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Genes Dev. 2005, 19:776-781.
44. Holt S.E., Aisner D.L., Shay J.W., Wright W.E. Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10687-10692.
45. Yi X., Tesmer V.M., Savre-Train I., Shay J.W., Wright W.E. Both transcriptional and post-transcriptional mechanisms regulate human telomerase template RNA (hTR) levels. Mol. Cell. Biol. 1999, 19:3989-3997.
46. Lee J.H., Khadka P., Baek S.H., Chung I.K. CHIP promotes human telomerase reverse transcriptase degradation and negatively regulates telomerase activity. J. Biol. Chem. 2010, 285:42033-42045.
47. Wong J.M., Kusdra L., Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell Biol. 2002, 4:731-736.
48. Tomlinson R.L., Ziegler T.D., Supakorndej T., Terns R.M., Terns M.P. Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 2006, 17:955-965.
49. Venteicher A.S., Abreu E.B., Meng Z., McCann K.E., Terns R.M., Veenstra T.D., Terns M.P., Artandi S.E. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 2009, 323:644-648.
50. Venteicher A.S., Artandi S.E. TCAB1: driving telomerase to Cajal bodies. Cell Cycle 2009, 8:1329-1331.
51. Zhao Y., Abreu E., Kim J., Stadler G., Eskiocak U., Terns M.P., Terns R.M., Shay J.W., Wright W.E. Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions. Mol. Cell 2011, 42:297-307.
52. Lin J., Jin R., Zhang B., Yang P.X., Chen H., Bai Y.X., Xie Y., Huang C., Huang J. Characterization of a novel effect of hPinX1 on hTERT nucleolar localization. Biochem. Biophys. Res. Commun. 2007, 353:946-952.
53. Banik S.S., Counter C.M. Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR. J. Biol. Chem. 2004, 279:51745-51748.
54. Zhou X.Z., Lu K.P. The Pin2/TRF1-interacting protein PinX1 is an potent telomerase inhibitor. Cell 2001, 107:347-359.
55. Lin J., Blackburn E.H. Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA. Genes Dev. 2004, 18:387-396.
56. Feng J., Funk W.D., Wang S.-S., Weinrich S.L., Avilion A.A., Chiu C.-P., Adams R.R., Chang E., Allsopp R.C., Yu J., Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., Villeponteau B. The RNA component of human telomerase. Science 1995, 269:1236-1241.
57. Soder A.I., Going J.J., Kaye S.B., Keith W.N. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene 1998, 16:979-983.
58. Kim N.K., Theimer C.A., Mitchell J.R., Collins K., Feigon J. Effect of pseudouridylation on the structure and activity of the catalytically essential P6.1 hairpin in human telomerase RNA. Nucleic Acids Res. 2010, 38:6746-6756.
59. Liu Y., Snow B.E., Hande M.P., Yeung D., Erdmann N.J., Wakeham A., Itie A., Siderovski D.P., Lansdorp P.M., Robinson M.O., Harrington L. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr. Biol. 2000, 10:1459-1462.
60. Chiang Y.J., Hemann M.T., Hathcock K.S., Tessarollo L., Feigenbaum L., Hahn W.C., Hodes R.J. Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo. Mol. Cell. Biol. 2004, 24:7024-7031.
61. Hathcock K.S., Hemann M.T., Opperman K.K., Strong M.A., Greider C.W., Hodes R.J. Haploinsufficiency of mTR results in defects in telomere elongation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3591-3596.
62. Harrington L. Making the most of a little: dosage effects in eukaryotic telomere length maintenance. Chromosome Res. 2005, 13:493-504.
63. Soder A.I., Hoare S.F., Muir S., Going J.J., Parkinson E.K., Keith W.N. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997, 14:1013-1021.
64. Bryce L.A., Morrison N., Hoare S.F., Muir S., Keith W.N. Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15.33 by fluorescence in situ hybridization. Neoplasia 2000, 2:197-201.
65. Saretzki G., Petersen S., Petersen I., Kolble K., von Zglinicki T. hTERT gene dosage correlates with telomerase activity in human lung cancer cell lines. Cancer Lett. 2002, 176:81-91.
66. Yokoi S., Yasui K., Iizasa T., Imoto I., Fujisawa T., Inazawa J. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. Clin. Cancer Res. 2003, 9:4705-4713.
67. Angelopoulou K., Zavlaris M., Papaioannou N., Vlemmas I. Canis familiaris telomerase reverse transcriptase undergoes alternative splicing. Mamm. Genome 2008, 19:647-653.
68. Guo W., Okamoto M., Park N.H., Lee Y.M. Cloning and expression of hamster telomerase catalytic subunit cDNA. Int. J. Mol. Med. 2001, 8:73-78.
69. Chang H., Delany M.E. Complicated RNA splicing of chicken telomerase reverse transcriptase revealed by profiling cells both positive and negative for telomerase activity. Gene 2006, 379:33-39.
70. Rao F., Wang T., Li M., Li Z., Hong N., Zhao H., Yan Y., Lu W., Chen T., Wang W., Lim M., Yuan Y., Liu L., Zeng L., Wei Q., Guan G., Li C., Hong Y. Medaka tert produces multiple variants with differential expression during differentiation in vitro and in vivo. Int. J. Biol. Sci. 2011, 7:426-439.
71. Heller-Uszynska K., Schnippenkoetter W., Kilian A. Cloning and characterization of rice (Oryza sativa L) telomerase reverse transcriptase, which reveals complex splicing patterns. Plant J. 2002, 31:75-86.
72. Kilian A., Bowtell D.D.L., Abud H.E., Hime G.R., Venter D.J., Keese P.K., Duncan E.L., Reddel R.R., Jefferson R.A. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cells. Hum. Mol. Genet. 1997, 6:2011-2019.
73. Ulaner G.A., Hu J.F., Vu T.H., Giudice L.C., Hoffman A.R. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 1998, 58:4168-4172.
74. Colgin L.M., Wilkinson C., Englezou A., Kilian A., Robinson M.O., Reddel R.R. The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2000, 2:426-432.
75. Yi X., White D.M., Aisner D.L., Baur J.A., Wright W.E., Shay J.W. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2000, 2:433-440.
76. Saeboe-Larssen S., Fossberg E., Gaudernack G. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol. Biol. 2006, 7:26.
77. Amor S., Remy S., Dambrine G., Le Vern Y., Rasschaert D., Laurent S. Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo. BMC Cancer 2010, 10:571.
78. Rha S.Y., Jeung H.C., Park K.H., Kim J.J., Chung H.C. Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. Oncol. Res. 2009, 18:213-220.
79. Lincz L.F., Mudge L.M., Scorgie F.E., Sakoff J.A., Hamilton C.S., Seldon M. Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. Neoplasia 2008, 10:1131-1137.
80. Karamysheva Z., Wang L., Shrode T., Bednenko J., Hurley L.A., Shippen D.E. Developmentally programmed gene elimination in Euplotes crassus facilitates a switch in the telomerase catalytic subunit. Cell 2003, 113:565-576.
81. Cifuentes-Rojas C., Kannan K., Tseng L., Shippen D.E. Two RNA subunits and POT1a are components of Arabidopsis telomerase. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:73-78.
82. C. Cifuentes-Rojas, A.D. Nelson, K. Kannan, D.E. Shippen, A novel regulatory network for Arabidopsis telomerase fueled by TER duplication and processing, and assembly of alternative RNP particles, in preparation.
83. J. Stewart, M. Chaiken, W. Feng, C. Price, Regulation of telomere length, Mutat. Res., in press, Sept 17. [Epub ahead of print].
84. Nugent C.I., Hughes T.R., Lue N.F., Lundblad V. Cdc13p: a single-strand telomeric DNA binding protein with a dual role in yeast telomere maintenance. Science 1996, 274:249-252.
85. Marcand S., Brevet V., Mann C., Gilson E. Cell cycle restriction of telomere elongation. Curr. Biol. 2000, 10:487-490.
86. Osterhage J.L., Talley J.M., Friedman K.L. Proteasome-dependent degradation of Est1p regulates the cell cycle-restricted assembly of telomerase in Saccharomyces cerevisiae. Nat. Struct. Mol. Biol. 2006, 13:720-728.
87. Li S., Makovets S., Matsuguchi T., Blethrow J.D., Shokat K.M., Blackburn E.H. Cdk1-dependent phosphorylation of Cdc13 coordinates telomere elongation during cell-cycle progression. Cell 2009, 136:50-61.
88. Ritchie K.B., Mallory J.C., Petes T.D. Interactions of TLC1 (which encodes the RNA subunit of telomerase), TEL1, and MEC1 in regulating telomere length in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 1999, 19:6065-6074.
89. Bianchi A., Shore D. Increased association of telomerase with short telomeres in yeast. Genes Dev. 2007, 21:1726-1730.
90. Tseng S.F., Lin J.J., Teng S.C. The telomerase-recruitment domain of the telomere binding protein Cdc13 is regulated by Mec1p/Tel1p-dependent phosphorylation. Nucleic Acids Res. 2006, 34:6327-6336.
91. Hector R.E., Shtofman R.L., Ray A., Chen B.R., Nyun T., Berkner K.L., Runge K.W. Tel1p preferentially associates with short telomeres to stimulate their elongation. Mol. Cell 2007, 27:851-858.
92. Gao H., Toro T.B., Paschini M., Braunstein-Ballew B., Cervantes R.B., Lundblad V. Telomerase recruitment in Saccharomyces cerevisiae is not dependent on Tel1-mediated phosphorylation of Cdc13. Genetics 2010, 186:1147-1159.
93. DeZwaan D.C., Freeman B.C. The conserved Est1 protein stimulates telomerase DNA extension activity. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17337-17342.
94. Taggart A.K., Teng S.C., Zakian V.A. Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science 2002, 297:1023-1026.
95. Singh S.M., Lue N.F. Ever shorter telomere 1 (EST1)-dependent reverse transcription by Candida telomerase in vitro: evidence in support of an activating function. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5718-5723.
96. Peterson S.E., Stellwagen A.E., Singer D.S.J.M.S., Haimberger Z.W., Johnson C.O., Tzoneva M., Gottschling D.E. The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku. Nat. Genet. 2001, 27:64-67.
97. Stellwagen A.E., Haimberger Z.W., Veatch J.R., Gottschling D.E. Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends. Genes Dev. 2003, 14:2384-2395.
98. Gravel S., Larrivee M., Labrecque P., Wellinger R.J. Yeast Ku as a regulator of chromsomal DNA structure. Science 1998, 280:741-744.
99. Fisher T.S., Taggart A.K., Zakian V.A. Cell cycle-dependent regulation of yeast telomerase by Ku. Nat. Struct. Mol. Biol. 2004, 11:1198-1205.
100. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19:2100-2110.
101. Abreu E., Aritonovska E., Reichenbach P., Cristofari G., Culp B., Terns R.M., Lingner J., Terns M.P. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol. Cell. Biol. 2010, 30:2971-2982.
102. Xin H., Liu D., Wan M., Safari A., Kim H., Sun W., O'Connor M.S., Songyang Z. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007, 445:559-562.
103. Zaug A.J., Podell E.R., Nandakumar J., Cech T.R. Functional interaction between telomere protein TPP1 and telomerase. Genes Dev. 2010, 24:613-622.
104. Robart A.R., Collins K. Human telomerase domain interactions capture DNA for TEN domain-dependent processive elongation. Mol. Cell 2011, 42:308-318.
105. Zaug A.J., Podell E.R., Cech T.R. Mutation in TERT separates processivity from anchor-site function. Nat. Struct. Mol. Biol. 2008, 15:870-872.
106. Hockemeyer D., Palm W., Else T., Daniels J.P., Takai K.K., Ye J.Z., Keegan C.E., de Lange T., Hammer G.D. Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nat. Struct. Mol. Biol. 2007, 14:754-761.
107. Min B., Collins K. An RPA-related sequence-specific DNA-binding subunit of telomerase holoenzyme is required for elongation processivity and telomere maintenance. Mol. Cell 2009, 36:609-619.
108. Lei M., Zaug A.J., Podell E.R., Cech T.R. Switching human telomerase on and off with hPOT1 protein in vitro. J. Biol. Chem. 2005, 280:20449-20456.
109. Wang F., Podell E.R., Zaug A.J., Yang Y., Baciu P., Cech T.R., Lei M. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007, 445:506-510.
110. Teixeira M.T., Arneric M., Sperisen P., Lingner J. Telomere length homeostasis is achieved via a switch between telomerase-extendible and -nonextendible states. Cell 2004, 117:323-335.
111. Shakirov E.V., Shippen D.E. Length regulation and dynamics of individual telomere tracts in wild-type Arabidopsis. Plant Cell 2004, 16:1959-1967.
112. Liu Y., Kha H., Ungrin M., Robinson M.O., Harrington L. Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3597-3602.
113. Chang M., Arneric M., Lingner J. Telomerase repeat addition processivity is increased at critically short telomeres in a Tel1-dependent manner in Saccharomyces cerevisiae. Genes Dev. 2007, 21:2485-2494.
114. Zhao Y., Sfeir A.J., Zou Y., Buseman C.M., Chow T.T., Shay J.W., Wright W.E. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 2009, 138:463-475.
115. Boule J.B., Vega L.R., Zakian V.A. The yeast Pif1p helicase removes telomerase from telomeric DNA. Nature 2005, 438:57-61.
116. Schulz V.P., Zakian V.A. The Saccharomyces PIF1 DNA helicase inhibits telomere elongation and de novo telomere formation. Cell 1994, 76:145-155.
117. Makovets S., Blackburn E.H. DNA damage signalling prevents deleterious telomere addition at DNA breaks. Nat. Cell Biol. 2009, 11:1383-1386.
118. Snow B.E., Mateyak M., Paderova J., Wakeham A., Iorio C., Zakian V., Squire J., Harrington L. Murine Pif1 interacts with telomerase and is dispensable for telomere function in vivo. Mol. Cell. Biol. 2007, 27:1017-1026.
119. Mateyak M.K., Zakian V.A. Human PIF helicase is cell cycle regulated and associates with telomerase. Cell Cycle 2006, 5:2796-2804.
120. Azzalin C.M., Reichenbach P., Khoriauli L., Giulotto E., Lingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007, 318:798-801.
121. Luke B., Panza A., Redon S., Iglesias N., Li Z., Lingner J. The Rat1p 5' to 3' exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in Saccharomyces cerevisiae. Mol. Cell. 2008, 32:465-477.
122. Schoeftner S., Blasco M.A. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell. Biol. 2008, 10:228-236.
123. Vrbsky J., Akimcheva S., Watson J.M., Turner T.L., Daxinger L., Vyskot B., Aufsatz W., Riha K. siRNA-mediated methylation of Arabidopsis telomeres. PLoS Genet. 2010, 6:e1000986.
124. Feuerhahn S., Iglesias N., Panza A., Porro A., Lingner J. TERRA biogenesis, turnover and implications for function. FEBS Lett. 2010, 584:3812-3818.
125. Lopez de Silanes I., Stagno d'Alcontres M., Blasco M.A. TERRA transcripts are bound by a complex array of RNA-binding proteins. Nat. Commun. 2010, 1:33.
126. Redon S., Reichenbach P., Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 2010, 38:5797-5806.
127. Flynn R.L., Centore R.C., O'Sullivan R.J., Rai R., Tse A., Songyang Z., Chang S., Karlseder J., Zou L. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 2011, 471:532-536.
128. Ford L.P., Wright W.E., Shay J.W. A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation. Oncogene 2002, 21:580-583.